Patents by Inventor Albert Baldwin

Albert Baldwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Muscular Wasting Diseases Using NF-kB Activation Inhibitors
    Publication number: 20070225315
    Abstract: Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-?B activation inhibitor capable of blocking the activation of NF-?B.
    Type: Application
    Filed: March 15, 2007
    Publication date: September 27, 2007
    Applicant: THERALOGICS, INC.
    Inventors: Denis Guttridge, Albert Baldwin
  • Use of NF-kB Inhibition in Combination Therapy for Cancer
    Publication number: 20070110828
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: September 27, 2006
    Publication date: May 17, 2007
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang
  • Use of NF-kB Inhibition in Combination Therapy for Cancer
    Publication number: 20070105751
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: September 27, 2006
    Publication date: May 10, 2007
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang
  • Nuclear factors associated with transcriptional regulation
    Publication number: 20060063709
    Abstract: Constitutive and tissue-specific protein factors which bind to transcriptional regulatory elements of Ig genes (promoter and enhancer) are described. The factors were identified and isolated by an improved assay for protein-DNA binding. Genes encoding factors which positively regulate transcription can be isolated and employed to enhance transcription of Ig genes. In particular, NF-kB, the gene encoding NF-kB, IkB and the gene encoding IkB and uses therefor.
    Type: Application
    Filed: January 4, 2002
    Publication date: March 23, 2006
    Inventors: David Baltimore, Ranjan Sen, Phillip Sharp, Harinder Singh, Louis Staudt, Jonathan LeBowitz, Albert Baldwin, Roger Clerc, Lynn Corcoran, Patrick Baeuerle, Michael Lenardo, Chen-Ming Fan, Thomas Maniatis
  • Methods for treating or preventing GVHD
    Publication number: 20050208036
    Abstract: Methods are provided for administering alloreactive T cells to transplant recipients such that the risk of graft-versus-host disease is reduced.
    Type: Application
    Filed: January 10, 2005
    Publication date: September 22, 2005
    Inventors: Bruce Blazar, Matthew O'Shaughnessy, Christine Vogtenhuber, Jonathan Serody, Albert Baldwin
  • Use of NF-kB inhibition in combination therapy for cancer
    Publication number: 20050123506
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Application
    Filed: November 2, 2004
    Publication date: June 9, 2005
    Inventors: Albert Baldwin, James Cusack, Marty Mayo, Cun-Yu Wang